GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (AQSE:MYIG) » Definitions » Days Sales Outstanding

Mydecine Innovations Group (AQSE:MYIG) Days Sales Outstanding : 0.00 (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mydecine Innovations Group Days Sales Outstanding?

Mydecine Innovations Group's average Accounts Receivable for the three months ended in Jun. 2024 was £0.00 Mil. Mydecine Innovations Group's Revenue for the three months ended in Jun. 2024 was £0.00 Mil.

The historical rank and industry rank for Mydecine Innovations Group's Days Sales Outstanding or its related term are showing as below:

During the past 11 years, Mydecine Innovations Group's highest Days Sales Outstanding was 3406.67. The lowest was 834.29. And the median was 2120.48.

AQSE:MYIG's Days Sales Outstanding is not ranked *
in the Drug Manufacturers industry.
Industry Median: 71.7
* Ranked among companies with meaningful Days Sales Outstanding only.

Mydecine Innovations Group's Days Sales Outstanding stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00).


Mydecine Innovations Group Days Sales Outstanding Historical Data

The historical data trend for Mydecine Innovations Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Days Sales Outstanding Chart

Mydecine Innovations Group Annual Data
Trend Aug14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2,920.00 821.25 - -

Mydecine Innovations Group Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Mydecine Innovations Group's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Mydecine Innovations Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mydecine Innovations Group's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mydecine Innovations Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Mydecine Innovations Group's Days Sales Outstanding falls into.



Mydecine Innovations Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Mydecine Innovations Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

Mydecine Innovations Group's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

Days Sales Outstanding (Q: Jun. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2024 ) + Accounts Receivable (A: Jun. 2024 )) / count ) / Revenue (A: Jun. 2024 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mydecine Innovations Group  (AQSE:MYIG) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Mydecine Innovations Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Mydecine Innovations Group Business Description

Traded in Other Exchanges
Address
1890 – 1075 West Georgia Street, Suite 810, Vancouver, BC, CAN, V6E 3C9
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group Headlines

No Headlines